Erk 1/2 and survivin could contribute to imatinib resistance in CML cell line independent of Bcr-Abl

dc.contributor.authorSilva, Danielle Cardoso da
dc.contributor.authorMoreira, Miguel Angelo Martins
dc.contributor.authorMaia, Raquel Ciuvalschi
dc.contributor.authorVasconcelos, Flavia da Cunha
dc.date.accessioned2021-12-06T16:24:51Z
dc.date.available2021-12-06T16:24:51Z
dc.date.issued2016
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/4730
dc.publisherINCApt_BR
dc.titleErk 1/2 and survivin could contribute to imatinib resistance in CML cell line independent of Bcr-Ablpt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Daniela final.pdf
Size:
1.68 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: